Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 4 | 2023 | 51 | 1.920 |
Why?
|
CD8-Positive T-Lymphocytes | 12 | 2024 | 4438 | 0.930 |
Why?
|
Lymphocytic Choriomeningitis | 4 | 2019 | 132 | 0.910 |
Why?
|
Lymphocytic choriomeningitis virus | 3 | 2019 | 168 | 0.860 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.710 |
Why?
|
Adaptive Immunity | 1 | 2019 | 712 | 0.470 |
Why?
|
Gene Transfer Techniques | 1 | 2019 | 1224 | 0.460 |
Why?
|
Melanoma, Experimental | 3 | 2019 | 559 | 0.390 |
Why?
|
Immunotherapy | 5 | 2023 | 4414 | 0.390 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1255 | 0.390 |
Why?
|
T-Lymphocytes | 7 | 2023 | 10163 | 0.350 |
Why?
|
Melanoma | 4 | 2023 | 5462 | 0.320 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2542 | 0.300 |
Why?
|
Genetic Testing | 2 | 2021 | 3439 | 0.290 |
Why?
|
Immunity, Innate | 1 | 2019 | 2956 | 0.290 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2723 | 0.280 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2019 | 1368 | 0.280 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6347 | 0.250 |
Why?
|
Tumor Escape | 2 | 2017 | 349 | 0.240 |
Why?
|
Immunologic Memory | 3 | 2019 | 1348 | 0.220 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3564 | 0.210 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2022 | 56 | 0.210 |
Why?
|
T-Box Domain Proteins | 2 | 2022 | 471 | 0.200 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2022 | 154 | 0.200 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 21821 | 0.190 |
Why?
|
Phosphate-Binding Proteins | 1 | 2021 | 70 | 0.190 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16665 | 0.190 |
Why?
|
Interferon Regulatory Factors | 1 | 2022 | 270 | 0.180 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2021 | 199 | 0.180 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5662 | 0.180 |
Why?
|
Mice | 16 | 2024 | 81045 | 0.180 |
Why?
|
Gelatinases | 1 | 2018 | 94 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2022 | 9735 | 0.160 |
Why?
|
Interferon Type I | 2 | 2019 | 542 | 0.160 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 254 | 0.160 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2018 | 55 | 0.160 |
Why?
|
Vero Cells | 1 | 2019 | 485 | 0.160 |
Why?
|
Immune System | 1 | 2023 | 804 | 0.160 |
Why?
|
Animals | 20 | 2024 | 168561 | 0.160 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.150 |
Why?
|
Alanine | 1 | 2019 | 572 | 0.150 |
Why?
|
Neoplasms | 4 | 2023 | 21596 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1038 | 0.140 |
Why?
|
Transplantation Chimera | 1 | 2019 | 612 | 0.140 |
Why?
|
Protein Multimerization | 1 | 2021 | 971 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5163 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2018 | 320 | 0.130 |
Why?
|
Mice, Knockout | 4 | 2023 | 14554 | 0.130 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1983 | 0.130 |
Why?
|
Immunity | 1 | 2020 | 1011 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1274 | 0.120 |
Why?
|
Lymphocyte Activation | 3 | 2019 | 5519 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 540 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2020 | 4200 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1073 | 0.110 |
Why?
|
Stromal Cells | 1 | 2018 | 1353 | 0.110 |
Why?
|
Cell Lineage | 2 | 2019 | 2504 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6313 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1372 | 0.110 |
Why?
|
Signal Transduction | 3 | 2021 | 23387 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2906 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2763 | 0.100 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3639 | 0.090 |
Why?
|
Cell Adhesion Molecules, Neuronal | 2 | 2023 | 265 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2915 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2257 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1337 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2019 | 3420 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2019 | 5062 | 0.080 |
Why?
|
Fibroblasts | 1 | 2019 | 4143 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8621 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3465 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2022 | 11470 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3691 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18006 | 0.070 |
Why?
|
Genomics | 2 | 2019 | 5692 | 0.070 |
Why?
|
Formates | 1 | 2023 | 43 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6259 | 0.060 |
Why?
|
Germ-Free Life | 1 | 2023 | 188 | 0.050 |
Why?
|
Colorectal Neoplasms | 2 | 2019 | 6754 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7873 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 808 | 0.050 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2020 | 86 | 0.050 |
Why?
|
Nitric Oxide | 2 | 2019 | 2128 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2020 | 10472 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 99 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12705 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2021 | 576 | 0.040 |
Why?
|
Female | 7 | 2022 | 379592 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 315 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 939 | 0.040 |
Why?
|
Humans | 13 | 2023 | 742088 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13655 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2018 | 289 | 0.040 |
Why?
|
Inflammasomes | 1 | 2021 | 493 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 12071 | 0.030 |
Why?
|
Pericytes | 1 | 2018 | 291 | 0.030 |
Why?
|
Chromatin | 2 | 2018 | 2917 | 0.030 |
Why?
|
Down-Regulation | 1 | 2023 | 3001 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2017 | 230 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1727 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 628 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 284 | 0.030 |
Why?
|
Endopeptidases | 1 | 2018 | 772 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2020 | 1144 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2569 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 704 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6474 | 0.030 |
Why?
|
Autophagy | 1 | 2020 | 1301 | 0.030 |
Why?
|
Fatty Acids | 1 | 2020 | 1806 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1606 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2107 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2017 | 1284 | 0.020 |
Why?
|
Male | 2 | 2019 | 349538 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 62966 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20774 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3294 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1806 | 0.020 |
Why?
|
Protein Binding | 1 | 2023 | 9387 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3199 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6382 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5872 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2500 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2016 | 1027 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3618 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3769 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 19223 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7721 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.010 |
Why?
|
HIV Infections | 1 | 2016 | 16678 | 0.010 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(54)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_